Cognios Beta Neutral Large Cap Fund’s Gilead Sciences GILD Stock Holding History

Cognios Beta Neutral Large Cap Fund’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$495K	Sell	6,756 -138	-2%	-$10.6K	0.64%	64
2023 Q4	$558K	Sell	6,894 -907	-12%	-$70.6K	0.73%	54
2023 Q3	$585K	Sell	7,801 -1,388	-15%	-$107K	0.76%	52
2023 Q2	$708K	Sell	9,189 -4,337	-32%	-$346K	0.82%	50
2023 Q1	$1.1M	Sell	13,526 -609	-4%	-$50.4K	1.05%	21
2022 Q4	$1.21M	Buy	+14,135	New	+$1.12M	1.16%	15
2018 Q2	$1.62M	Buy	+22,840	New	+$1.61M	0.57%	99

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cognios Beta Neutral Large Cap Fund's GILD Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund reduced its Gilead Sciences (GILD) stake by 2% in Q1 2024, selling an estimated $10.6K and leaving 6,756 shares worth $495K. The position accounts for 0.64% of the portfolio, ranked #64.

Cognios Beta Neutral Large Cap Fund first reported a position in GILD in Q2 2018 and has held it in 7 quarters since. The position peaked at $1.62M in Q2 2018. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

Cognios Beta Neutral Large Cap Fund held 6,756 shares of Gilead Sciences worth $495K as of Q1 2024.
Cognios Beta Neutral Large Cap Fund sold 138 Gilead Sciences shares in Q1 2024, an estimated $10.6K.
Gilead Sciences made up 0.64% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #64 holding.
Cognios Beta Neutral Large Cap Fund first reported a position in Gilead Sciences in Q2 2018 and has held it in 7 quarters since.
Cognios Beta Neutral Large Cap Fund's Gilead Sciences position peaked at $1.62M in Q2 2018.
1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.